167 related articles for article (PubMed ID: 19805200)
1. Thrombospondin-1 is a critical effector of oncosuppressive activity of sst2 somatostatin receptor on pancreatic cancer.
Laklai H; Laval S; Dumartin L; Rochaix P; Hagedorn M; Bikfalvi A; Le Guellec S; Delisle MB; Schally AV; Susini C; Pyronnet S; Bousquet C
Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17769-74. PubMed ID: 19805200
[TBL] [Abstract][Full Text] [Related]
2. sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells.
Delesque N; Buscail L; Estève JP; Saint-Laurent N; Müller C; Weckbecker G; Bruns C; Vaysse N; Susini C
Cancer Res; 1997 Mar; 57(5):956-62. PubMed ID: 9041201
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the bystander effect of somatostatin receptor sst2 after in vivo gene transfer into human pancreatic cancer cells.
Carrere N; Vernejoul F; Souque A; Asnacios A; Vaysse N; Pradayrol L; Susini C; Buscail L; Cordelier P
Hum Gene Ther; 2005 Oct; 16(10):1175-93. PubMed ID: 16218779
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer.
Rochaix P; Delesque N; Estève JP; Saint-Laurent N; Voight JJ; Vaysse N; Susini C; Buscail L
Hum Gene Ther; 1999 Apr; 10(6):995-1008. PubMed ID: 10223733
[TBL] [Abstract][Full Text] [Related]
5. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis.
Guillermet J; Saint-Laurent N; Rochaix P; Cuvillier O; Levade T; Schally AV; Pradayrol L; Buscail L; Susini C; Bousquet C
Proc Natl Acad Sci U S A; 2003 Jan; 100(1):155-60. PubMed ID: 12490654
[TBL] [Abstract][Full Text] [Related]
7. Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway.
Bousquet C; Guillermet-Guibert J; Saint-Laurent N; Archer-Lahlou E; Lopez F; Fanjul M; Ferrand A; Fourmy D; Pichereaux C; Monsarrat B; Pradayrol L; Estève JP; Susini C
EMBO J; 2006 Sep; 25(17):3943-54. PubMed ID: 16917505
[TBL] [Abstract][Full Text] [Related]
8. Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition.
Dong YW; Wang XP; Wu K
World J Gastroenterol; 2009 Jan; 15(4):441-8. PubMed ID: 19152448
[TBL] [Abstract][Full Text] [Related]
9. The proangiogenic phenotype of human tumor-derived endothelial cells depends on thrombospondin-1 downregulation via phosphatidylinositol 3-kinase/Akt pathway.
Bussolati B; Assenzio B; Deregibus MC; Camussi G
J Mol Med (Berl); 2006 Oct; 84(10):852-63. PubMed ID: 16924472
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats.
Iruela-Arispe ML; Lombardo M; Krutzsch HC; Lawler J; Roberts DD
Circulation; 1999 Sep; 100(13):1423-31. PubMed ID: 10500044
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor gene transfer inhibits established pancreatic cancer xenografts.
Celinski SA; Fisher WE; Amaya F; Wu YQ; Yao Q; Youker KA; Li M
J Surg Res; 2003 Nov; 115(1):41-7. PubMed ID: 14572771
[TBL] [Abstract][Full Text] [Related]
12. p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis.
Vikhanskaya F; Bani MR; Borsotti P; Ghilardi C; Ceruti R; Ghisleni G; Marabese M; Giavazzi R; Broggini M; Taraboletti G
Oncogene; 2001 Nov; 20(50):7293-300. PubMed ID: 11704858
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic effects of somatostatin receptor subtype 2 on human pancreatic cancer xenografts.
Kumar M; Liu ZR; Thapa L; Qin RY
Carcinogenesis; 2004 Nov; 25(11):2075-81. PubMed ID: 15205362
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models.
Vernejoul F; Faure P; Benali N; Calise D; Tiraby G; Pradayrol L; Susini C; Buscail L
Cancer Res; 2002 Nov; 62(21):6124-31. PubMed ID: 12414637
[TBL] [Abstract][Full Text] [Related]
15. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells.
Tenan M; Fulci G; Albertoni M; Diserens AC; Hamou MF; El Atifi-Borel M; Feige JJ; Pepper MS; Van Meir EG
J Exp Med; 2000 May; 191(10):1789-98. PubMed ID: 10811871
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of inhibition of growth of human pancreatic carcinoma implanted in nude mice by somatostatin receptor subtype 2.
Kumar M; Liu ZR; Thapa L; Wang DY; Tian R; Qin RY
Pancreas; 2004 Aug; 29(2):141-51. PubMed ID: 15257106
[TBL] [Abstract][Full Text] [Related]
18. HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy.
Wen XF; Yang G; Mao W; Thornton A; Liu J; Bast RC; Le XF
Oncogene; 2006 Nov; 25(52):6986-96. PubMed ID: 16715132
[TBL] [Abstract][Full Text] [Related]
19. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.
Buscail L; Saint-Laurent N; Chastre E; Vaillant JC; Gespach C; Capella G; Kalthoff H; Lluis F; Vaysse N; Susini C
Cancer Res; 1996 Apr; 56(8):1823-7. PubMed ID: 8620499
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1).
Greenaway J; Lawler J; Moorehead R; Bornstein P; Lamarre J; Petrik J
J Cell Physiol; 2007 Mar; 210(3):807-18. PubMed ID: 17154366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
